{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2287, 
        2301
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2459, 
        2473
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2670, 
        2684
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2886, 
        2900
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        5528, 
        5551
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3072, 
        3080
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4985, 
        4993
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1983, 
        2010
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        602, 
        631
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1732, 
        1758
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2135, 
        2158
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2204, 
        2227
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2278, 
        2286
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2450, 
        2458
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2661, 
        2669
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2877, 
        2885
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2305, 
        2318
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2479, 
        2492
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2690, 
        2703
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2906, 
        2919
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2320, 
        2331
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2494, 
        2505
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2705, 
        2716
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2921, 
        2932
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1770, 
        1780
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1806, 
        1816
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1842, 
        1856
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1882, 
        1891
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1917, 
        1926
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1952, 
        1960
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2105, 
        2115
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2174, 
        2184
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2243, 
        2252
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2420, 
        2429
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2632, 
        2641
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2844, 
        2852
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2092, 
        2094
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2161, 
        2163
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2230, 
        2232
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2407, 
        2409
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2619, 
        2621
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2831, 
        2833
      ]
    }
  ], 
  "Supplementary Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3812, 
        3844
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 7^2038^MOH|PIMS|CCO|20160503120200|90379AD3991735A5A6F133E27F9C3963990CDBDB|ORU^R01|999999|P|2.5|\nPID|1||9999999^^^^CMR^HOSPITAL 7&9999&MOH~9999999^^^^MRN^HOSPITAL 7&9999&MOH~9999999999&CV&ON^^^^JHN||XXXXXX^XXXXXX^XXXXXXX X||99999999|M|||999 XXXX XXX XX^^XXXXXXX^XX^X9X 9X9^XXX||(999)999-9999|(905)476-3712||||||||||||||||N|\nOBR|1||YS16-5391|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||201604070000|||66473^XXXXXXX^XXXX||||201604071456|PAT&&Prostate, right apex, needle biopsy|99999^XXXXXXX^XXXX||||N||201604131506||SRHCSP|F|||||||99999^XXXXX^XXXXXXX|\n\n\n\n\n\n\n\nPath report.gross description\n\nA. The specimen (prostate right apex lobe needle biopsy) is received in formalin and consists of 2 tan 1.3 cm cores of tissue. They are entirely submitted in blocks A1 and A2.\n\nB. The specimen (prostate right base lobe needle biopsy) is received in formalin and consists of 2 tan 1.8 and 1.9 cm cores of tissue. They are entirely submitted in blocks B1 and B2.\n\nC. The specimen (prostate, right mid lobe needle biopsy) is received in formalin and consists of 2 tan 1.8 and 2.1 cm cores of tissue. They are entirely submitted in blocks C1 and C2.\n\nD. The specimen (prostate, left apex lobe needle biopsy) is received in formalin and consists of 2 tan 1.3 and 1.4 cm cores of tissue. They are entirely submitted in blocks D1 and D2.\n\nE. The specimen (prostate, left base lobe needle biopsy) is received in formalin and consists of 2 tan 1.8 cm cores of tissue. They are entirely submitted in blocks E1 and E2.\n\nF. The specimen (prostate, left mid lobe needle biopsy) is received in formalin and consists of 2 tan 1.8 and 1.9 cm cores of tissue. They are entirely submitted in blocks F1 and F2.\nCN\n\n\n\n\nPath report.site of origin\n\nProstate, right apex, needle biopsy\nProstate, right base, needle biopsy\nProstate, right mid lobe, needle biopsy\nProstate, left apex, needle biopsy\nProstate, left base, needle biopsy\nProstate, left mid lobe, needle biopsy\n\n\nPath report.final diagnosis\n\n***PRELIMINARY DIAGNOSIS*** - SENT FOR CONSULTATION, FINAL DIAGNOSIS TO FOLLOW\n\nA. Prostate, right apex, needle biopsy: \n  Negative for malignancy\n \nB. Prostate, right base, needle biopsy: \n  Negative for malignancy\n \nC. Prostate, right mid lobe, needle biopsy: \n   Invasive adenocarcinoma\n   Gleason score: 6/ 10 (3+3)\n   Tumour present in 1/2 cores\n   Tumour volume estimated at 5% of biopsy\n\nD. Prostate, left apex, needle biopsy: \n   Invasive adenocarcinoma\n   - Gleason score: 6/ 10 (3+3)\n   - Tumour present in 2/2 cores\n   - Tumour volume estimated at 1% of biopsy\n  - Perineural invasion - present\n\nE. Prostate, left base, needle biopsy: \n  Invasive adenocarcinoma\n   - Gleason score: 6/ 10 (3+3) \n   - Tumour present in 1/2 cores\n   - Tumour volume estimated at 5% of biopsy\n   - Perineural invasion present\n \nF. Prostate, left mid lobe, needle biopsy: \n  Invasive adenocarcinoma\n   - Gleason score: 6/ 10 (3+3)\n   - Tumour present in 2/2 cores\n   - Tumour volume estimated at 15% of biopsy\n   - Perineural invasion present\n\n   - Please see comment \n\nCOMMENT: In the background of prostatic adenocarcinoma described above there is intraluminal proliferation of possible ducts associated with scant basal cells at the periphery. I am not certain whether this represents a benign proliferation, ductal carcinoma, intraductal carcinoma or high grade PIN. \n\nSecondly there is a focus in the biopsy from left mid lobe (block F 2) shows perineural invasion which includes a ganglion cell; I am not sure whether this is an indication of extraprostatic extension. \n\nFor the above above reasons, I am referring this case to the GU pathology group at HOSPITAL Health Science Centre for their expert opinion. The final diagnosis will follow when a copy of their report is received. \n\nRI/SC\nRO/SHSC \n\n\n\nPath report.supplemental reports\n\n\n\n\n***FINAL DIAGNOSIS***\n\n\nA. Prostate, right apex, needle biopsy: \n  Negative for malignancy\n \nB. Prostate, right base, needle biopsy: \n  Negative for malignancy\n \nC. Prostate, right mid lobe, needle biopsy: \n   Invasive adenocarcinoma\n   - Gleason score: 3+3, 6/10\n   - Tumour present in 1/2 cores\n   - Tumour volume estimated at 5% of biopsy\n\nD. Prostate, left apex, needle biopsy: \n   Invasive adenocarcinoma\n   - Gleason score: 3+3, 6/10\n   - Tumour present in 2/2 cores\n   - Tumour volume estimated at 1 % of biopsy\n   - Perineural invasion present\n   - Intraductal carcinoma present\n \nE. Prostate, left base, needle biopsy: \n   Invasive adenocarcinoma\n   - Gleason score: 3+4, 7/10\n   - Tumour present in 1/2 cores\n   - Tumour volume estimated at 1 % of biopsy\n   - Perineural invasion present\n   - Intraductal carcinoma present   \n\n \nF. Prostate, left mid lobe, needle biopsy: \n   Invasive adenocarcinoma\n   - Gleason score: 3+3, 6/10\n   - Tumour present in 2/2 cores\n   - Tumour volume estimated at 15% of biopsy\n   - Perineural invasion present\n   - Intraductal carcinoma present   \n\n   - Please see comment and attached report\n\nCOMMENT: This case is reviewed by Dr. Linda Sugar at HOSPITAL Health Science Centre and the above diagnosis reflects her opinion. Her report is attached and should be read in detail. In her opinion there is intraductal carcinoma present on the left side and there is focal Gleason pattern 4 adenocarcinoma (in left base, specimen E). In addition her synoptic report indicates there is no evidence of periprostatic fat invasion. \n\nNote: As the synoptic for this case was provided by the consulting pathologist it is not being repeated.\n\n \n \n\n\n\nPath report.relevant Hx\n\nProstate cancer on surveillance. Now PSA 19\n\n\n\n"
}